In the news

September 30, 2021

Scientists reverse pancreatic cancer progression in ‘time machine’ made of human cells

Bumsoo Han, professor of mechanical engineering, has built a realistic model of a pancreatic structure that acts as a “time machine” to understand cancer and reverse its spread.

September 9, 2021

Tyler Trent endowment leads to breakthrough discoveries in cancer research

“Tyler dreamed of raising a million dollars for cancer research and we have raised $2.7 million in his endowment here,” said Dr. Timothy Ratliff, Robert Wallace Miller Director of Purdue University Center for Cancer Research. The funds have led to breakthrough discoveries in chemotherapeutic studies focusing on highly resistant tumors like the very ones Tyler was battling.

December 1, 2020

Treating cancers starts small: More than 100 Purdue scientists study cancer on the cellular level

The Purdue University Center for Cancer Research connects more than 110 researchers from across the university to study cancer on the cellular level. The work in PCCR’s labs advances understandings of cancer prevention, detection, diagnosis and treatment. One of those faculty members is Deborah Knapp, the Dolores L. McCall Professor of Comparative Oncology, who is performing an ultrasound on a dog. PCCR is the nation’s only National Cancer Institute basic laboratory cancer center that includes a college of veterinary medicine.

October 29, 2020

Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests

Bumsoo Han, a professor of mechanical engineering, developed a tool that is helping scientists to more efficiently discover and test new drugs for pancreatic cancer.

October 22, 2020

Technology shines the light on ovarian cancer treatments

A Purdue University scientist is working to use simple LED light to help determine if certain chemotherapy options will work for specific patients.

October 8, 2020

Walther Cancer Foundation $11 million investment to expand IU-Purdue bioinformatics collaboration

The Walther Cancer Foundation will invest $11 million to advance collaborative cancer research at Indiana University and Purdue University by supporting scientists through bioinformatics — an increasingly critical aspect of their work.

October 6, 2020

Novel testing platform designed for breast cancer cells

A Purdue University team has developed a novel testing platform to evaluate how breast cancer cells respond to the recurrent stretching that occurs in the lungs during breathing.

August 10, 2020

Purdue scientist identifies new target for wide array of cancers

Purdue University’s Zhong-Yin Zhang’s team has discovered a novel “phosphatase cascade” that plays a critical role in pancreas, liver, kidney, lung, breast, prostate, brain and other types of cancers.

New treatment approach uses killer cells to treat deadly brain tumors

A Purdue University cancer innovator and his team have developed a promising new approach to treating these tumors using a type of immune cell called the natural killer (NK) cell.

Chemistry innovator widening, quickening uses of spectrometry

The clock is ticking when a neurosurgeon is trying to remove a brain tumor but also determining its malignancy and type. Instead of sending samples to a lab where the necessary testing equipment resides to answer those questions, a Purdue scientist is working on shrinking that equipment for use in the surgical room.